Table of Contents

🩺 Scoliosis Screening

Scoliosis screening is a public health strategy aimed at the early detection of spinal curvature abnormalities, especially *idiopathic scoliosis*, in asymptomatic children and adolescents.

πŸ” Core Elements

🎯 Goals

⚠️ Controversies

β€”-



RΓ­os-de-Moya-Angeler et al. evaluate a scoliosis screening program (PANA) where attendance drops from 73.2% to 20.5% between age groups, and only 15.3% complete all phases 1)

Conclusion: Evaluating effectiveness in a system with near-zero adherence is methodologically meaningless.

❝ This is like reviewing the efficiency of a train that never arrives. ❞

πŸ§ͺ 2. Methodological Fragility: Tiny Sample, Inflated Conclusions

From 881 initial subjects, only 127 were followed up β€” a biased 14.4%. Retrospective reliance on the visual forward bending test (FBT) without quantification undermines any clinical validity.

Red flag: You cannot draw robust conclusions from uncalibrated tools and a self-selected cohort.

🎯 3. Diagnostic Tools Misused: FBT β‰  Gold Standard

Visual FBT had only 5.9% sensitivity, with 11.1% false positives at age 13-14. Only 4% were positive when using a scoliometer >7Β°.

❝ It takes 9 years to learn a basic lesson: use an instrument, not your eyes. ❞

πŸ” 4. Circular Reasoning and Policy Naivety

The study calls for better-trained staff and use of the scoliometer in schools, but fails to address:

Policy fantasy: More of the same won’t fix foundational flaws.

🧠 5. Irrelevance for Specialists

No data on:

Conclusion: The study is disconnected from real-world scoliosis management and decision-making.

πŸ’£ Final Verdict: A Postmortem, Not a Study

This is not a validation β€” it is an autopsy. With no useful correlation to patient-centered outcomes, this study:

❝ Monitoring failure for a decade does not turn it into success. ❞
1)
Rios-de-Moya-Angeler R, Santonja-Medina F, Sanz-Mengibar JM, RΓ­os-BernabΓ© R, Hurtado-AvilΓ©s J, Santonja-Renedo F. Evaluation of a Primary Health Care Scoliosis Screening Program: A 9-Year Follow-Up Study. J Clin Med. 2025 May 30;14(11):3870. doi: 10.3390/jcm14113870. PMID: 40507630; PMCID: PMC12156459.